Browsing Tag
U.S. Healthcare
3 posts
Can Genentech’s $50 direct-to-patient Xofluza launch reshape access to flu antivirals in 2025?
Genentech slashes Xofluza price by 70% in a direct-to-patient launch with Amazon, Cost Plus, and Alto Pharmacy. See how this reshapes flu access in 2025.
dorsaVi (ASX: DVL) stock surges after Select Medical deal opens U.S. distribution for wearable rehab technology
dorsaVi (ASX: DVL) signs major five-year agreement with Select Medical for motion-sensor rehab tech. Find out why its stock is up 354% in a year.
Health Catalyst acquires Lumeon to enhance care orchestration capabilities
Health Catalyst, Inc. (Nasdaq: HCAT), a prominent player in healthcare data and analytics, has announced the completion of…